Activist investor Starboard Value says it will oppose Bristol-Myers' deal for Celgene

The activist investor said Thursday that it intends to use its stake in Bristol-Myers Squibb to oppose its acquisition of Celgene.

from Investing https://ift.tt/2GRSUvf
via IFTTT